EE03384B1 - Use of melatonin for the manufacture of a medicament - Google Patents

Use of melatonin for the manufacture of a medicament

Info

Publication number
EE03384B1
EE03384B1 EE9700166A EE9700166A EE03384B1 EE 03384 B1 EE03384 B1 EE 03384B1 EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A EE 03384 B1 EE03384 B1 EE 03384B1
Authority
EE
Estonia
Prior art keywords
melatonin
medicament
manufacture
Prior art date
Application number
EE9700166A
Other languages
Estonian (et)
Other versions
EE9700166A (en
Inventor
Zisapel Nava
Original Assignee
Neurim Pharmaceuticals (1991) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.
Publication of EE9700166A publication Critical patent/EE9700166A/en
Publication of EE03384B1 publication Critical patent/EE03384B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EE9700166A 1995-02-01 1996-01-29 Use of melatonin for the manufacture of a medicament EE03384B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
EE9700166A EE9700166A (en) 1998-02-16
EE03384B1 true EE03384B1 (en) 2001-04-16

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700166A EE03384B1 (en) 1995-02-01 1996-01-29 Use of melatonin for the manufacture of a medicament

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227002B1 (en) 2000-01-05 2010-04-28 Neurim Pharma 1991 Use of melatonin in the manufacture of controlled release medicament for the prevention or treatment of symptoms of hypertension
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
KR102317399B1 (en) 2012-01-26 2021-10-26 반다 파마슈티칼즈, 인코퍼레이티드. Treatment of circadian rhythm disorders
EP2934509B1 (en) 2012-12-18 2020-05-27 Vanda Pharmaceuticals Inc. Tasimelteon for the treatment of circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
LT3337462T (en) * 2016-10-31 2021-01-11 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229490T2 (en) * 1991-05-09 2000-02-17 Neurim Pharma 1991 Medicines containing melatonin
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
NZ298878A (en) 1999-05-28
SI9620022A (en) 1998-10-31
BG62876B1 (en) 2000-10-31
JPH10513177A (en) 1998-12-15
LV11940B (en) 1998-05-20
CN1083263C (en) 2002-04-24
NO312814B1 (en) 2002-07-08
LU90118B1 (en) 1997-11-13
NO973531L (en) 1997-09-30
MX9705856A (en) 1998-07-31
WO1996023496A1 (en) 1996-08-08
PL321630A1 (en) 1997-12-08
NO973531D0 (en) 1997-07-31
PL183148B1 (en) 2002-05-31
MD970254A (en) 1999-05-31
SK103097A3 (en) 1998-01-14
SK284521B6 (en) 2005-05-05
DK176081B1 (en) 2006-04-18
CZ291349B6 (en) 2003-02-12
TW483757B (en) 2002-04-21
IS4532A (en) 1997-07-25
ATA901396A (en) 2001-02-15
AT408188B (en) 2001-09-25
FI973185A (en) 1997-09-30
TR199700723T1 (en) 1998-02-21
CZ240597A3 (en) 1998-01-14
LV11940A (en) 1998-01-20
AU4457496A (en) 1996-08-21
IS1980B (en) 2005-01-14
EE9700166A (en) 1998-02-16
MD1716C2 (en) 2002-02-28
FI973185A0 (en) 1997-07-31
JP4516159B2 (en) 2010-08-04
BG101803A (en) 1998-04-30
AU695366B2 (en) 1998-08-13
CN1172431A (en) 1998-02-04
BR9607169A (en) 1997-11-11
FI119586B (en) 2009-01-15
DK89697A (en) 1997-07-30
MD1716B2 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
FI971279A (en) Drug
ATE192157T1 (en) THERAPEUTIC SPIRO-AZABICYCLIC COMPOUNDS
EE9800040A (en) Inhaler
CY2013020I2 (en) THE USE OF AN INGENANE COMPOUND FOR THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF CANCER
NO20040145L (en) Use of benzenesulfonamide derivatives for the manufacture of a medicament
ATE151622T1 (en) NASAL DILATATOR
EE9700013A (en) Therapeutic compounds
DE69624072D1 (en) The disposable protective mask
DE69510024T2 (en) syringe
IS4698A (en) inhaler
DK0830166T3 (en) inhaler
PT777457E (en) THE USE OF GLYCERYL TRIACETATE FOR THE TREATMENT OF ONICOMICOSES
NO975660D0 (en) Use of benzimidazoles for the manufacture of a drug for the treatment of liver chemistry
EE03384B1 (en) Use of melatonin for the manufacture of a medicament
EE9700168A (en) Bicyclic isothiourea derivatives for therapeutic use
NO993627D0 (en) Use of a compound for the manufacture of a medicament
DK0866699T3 (en) Use of cholinesterase inhibitors for the manufacture of a medicament for the treatment of xerostomy
DE59610423D1 (en) PARTICULAR MEDICINE
LV11966A (en) Anti-inflammatory medication for use
DE29516634U1 (en) Respiratory therapy device
NO962385L (en) Therapeutic amides
DE29505562U1 (en) Therapeutic headgear
DE29515670U1 (en) Therapeutic headband
DE29506604U1 (en) Ready infusion set
KR970003938U (en) Patient Assistance Helmet

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20070129